Pcol General Anesthetics
Pcol General Anesthetics
Induction
Factors To Consider:
1. Blood: Gas Partition Coefficient
Blood: Gas Partition Coefficient
2. Inspired Air Concentrations
• In terms of the extent of hepatic metabolism,
3. Breathing Rate
the rank order for the inhaled anesthetics:
Explanation:
Low Blood: Gas Partition Coefficient - mabilis
High gas so high solubility sa blood kaya ung partition ng
umeffect
blood malaki, dahil if soluble sa dugo so lahat ng blood
1. Low solubility in blood.
pupuntahan niya so lilibot pa siya sa buong body before
• Reaches high arterial tensions rapidly,
pumunta sa brain kaya matagal ung effect pero if low
which in turn results in rapid
solubility tumatagos lang sa dugo kaya mabilis effect.
equilibration with the brain.
2. Fast onset of action
Considerations: WEIGHT and FAT RATIO of a patient.
• Ex. Nitrous oxide
3. Necessary for quick removal of anesthetic
PHARMACOKINETICS
• Anesthetic potency is currently described by the
Low Solubility/Fast Onset/Removal Explanation:
MAC.
• The alveolar concentration of an inhaled
anesthetic that prevents movement in MECHANISM OF ACTION
50% of patients in response to a • They increase the sensitivity of GABAA receptors.
standardized stimulus. This causes a prolongation of the inhibitory
chloride ion current after a pulse of GABA
(inhibitory) release. Postsynaptic neuronal
excitability is thus diminished. (pinapadami ung
GABA w/c is an inhibitory, therefore nawawalan
ng malay)
• They block the excitatory postsynaptic current
of the nicotinic receptors.
Inhalational Anesthetics
Thiopental
▪ Prototype.
▪ Highly lipid soluble
• MOA: Act at GABA receptors (inhibitory),
potentiate endogenous GABA activity at the
receptor, direct effect on Cl-channel at higher
concentrations.
• Rapid Onset, short-acting.
• Others: Thiamylal, Methohexital. Neuroleptic-Opioid Combinations
• Build-up in adipose tissue. • Neurolept analgesia
• Side Effects: ▪ Droperidol + Fentanyl (Innovar)
1. Hypotension (brand name)
2. Airway obstruction ▪ Walang pain na nararamdaman
3. Apnea
Neuruleptanalgesics
2. Benzodiazepines ➢ Refers to the combination of short-acting
(Diazepam, Lorazepam, Midazolam) synthetic opioid agent (fentanyl) &
• Primary Use: Pre-medication butyrophenone (doperidol)
(pandagdag sa IV anesthetics) ➢ Very drowsy, responds to voice comman,
• MOA: Potentiate action of GABA analgesia is profound.
• Cause anterograde amnesia (loss of the ➢ Combination produces peripheral vasodilation
ability to create new memories) where it decreases in arterial blood pressure.
• Toxicity: Antagonized by Flumazenil ➢ If administered rapidly, cause skeletal muscle
• Note: Midazolam is the only water- rigidity
soluble form.
• Neurolept anesthesia
▪ Droperidol + Fentanyl + 65% N2O in
O2
• May cause neuroleptic malignant
syndrome
Propofol
• Notable Effects:
• Emulsion
• Reduction in cerebral blood flow
• Respiratory depressant
• May increase arrhythmogenicity with
epinephrine but by itself does not cause
arrhythmias or MI
• Anti-emetic effect
• Rapid onset and short duration of action.
• A sedative–hypnotic used for the induction and
maintenance of anesthesia or sedation
• An alkyl phenol
• Originally formulated in egg lecithin emulsion
▪ Anaphylactoid reactions
▪ Current formulation: 1% propofol in
10% soybean oil, 2.25% glycerol, 1.2%
egg phosphatide.
• Side Effects:
1. Pain on injection.
2. Hypotension.
3. Apnea.
Fospropofol • Similar structure with Ketoconazole
• Prodrug • Rapid induction
• Approved for sedation during monitored • Formulated in 35% propylene glycol
anesthesia care • Serious Effect:
• Metabolized to Propofol by enzyme Alkaline ▪ Depression of Steroidgenesis
Phosphatase ▪ Kasi diba similar structure siya with
ketoconazole, eh ang ketoconazole
Ketamine meron siyang mga adrenal effects, so if
• Aka Dissociative Agent same structure sila ganun din effect ni
• MOA: Noncompetitive blockade of the membrane etomidate it can also depress the genesis
effects of the excitatory neurotransmitter of formation of steroid hormones.
glutamic acid at the NMDA (N-methyl D- • Side Effect:
aspartate) receptor. 1. Myoclonic activity.
• Produces “emergence” phenomena 2. Nausea and vomiting (50%).
• Psychomimetic – “emergence reactions” 3. Cortisol suppression (steroid
• Vivid dreaming, extracorporeal hormones)
(floating "out-of-body") experience, 4. Pain on injection.
misperceptions, misinterpretations,
illusions Dexmedetomidine
• May be associated with euphoria, • Alpha 2 adrenergic agonist
excitement, confusion, fear • Hypnosis is due to stimulation of a2 receptors in
• Structure similar to PCP (phencyclidine – illegal the locus coeruleus (site of the brain that
hallucinogenic drug) principal site for NE synthesis)
• Analgesic • Use for short-term sedation of intubated and
• Dissociative anesthesia ventilated patients in ICU.
▪ Cataleptic appearance, eyes open,
reflexes intact, purposeless but
coordinated movements.
▪ Cataleptic – condition characterized by
lack of response of external stimuli and
muscular rigidity
• Stimulates sympathetic nervous system.
• Norketamine - Active metabolite
• Sensation of dissociation in 15 seconds.
• Unconsciousness in 30 seconds.
• Duration of unconsciousness = 10-15 minutes.
• Duration of analgesia = 40 minutes.
• Duration of amnesia = 1-2 hours
• Used in low doses for outpatient anesthesia in
combination with propofol and in children
undergoing painful procedures (eg, dressing
changes for burns).
“Emergence” phenomena
- Associated with postoperative disorientation,
sensory and perceptual illusions, and vivid
dreams.
Miscellaneous
Etomidate
• Potent ultra-short-acting non-barbiturate
hypnotic without analgesic property.
• Dose of 0.3 mg/kg will induce sleep that lasts
for approximately 5 minutes.
• Mechanism of Action: GABA-mimetic action